603077 和邦生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.1546.63322.82023.7790.370
总资产报酬率 ROA (%)0.1195.27618.11718.4830.280
投入资产回报率 ROIC (%)0.1325.90220.34920.4860.309

边际利润分析
销售毛利率 (%)10.11023.26142.85341.37918.796
营业利润率 (%)2.18117.47234.36735.9568.373
息税前利润/营业总收入 (%)2.39417.03834.53336.6742.595
净利润/营业总收入 (%)1.35814.49129.22230.3030.055

收益指标分析
经营活动净收益/利润总额(%)125.97197.559100.12499.2542,524.293
价值变动净收益/利润总额(%)-1.6874.8970.4870.753154.187
营业外收支净额/利润总额(%)-0.008-0.379-0.058-0.355-2,686.305

偿债能力分析
流动比率 (X)2.1232.6852.6031.4871.053
速动比率 (X)1.1391.4852.0471.1950.852
资产负债率 (%)23.26417.61918.00418.32923.287
带息债务/全部投入资本 (%)16.47510.4039.68610.54016.961
股东权益/带息债务 (%)501.087851.542922.881843.249488.789
股东权益/负债合计 (%)319.112452.708440.575433.641324.591
利息保障倍数 (X)11.255-46.256186.63543.3981.131

营运能力分析
应收账款周转天数 (天)50.47735.81117.61018.32136.070
存货周转天数 (天)235.768172.22872.18747.51582.198